Syntonix was formed to discover and develop novel therapeutic proteins for the treatment of chronic diseases such as hemophilia, anemia, multiple sclerosis ...
SYNTONIX is a Research and Development (R&D) company involved in product development and marketing with a diversified portfolio of products and solutions in ...
Jan 4, 2007 · Syntonix, a privately held biopharmaceutical company focused on discovering and developing long-acting therapeutic products to improve treatment ...
SYNTONIX is a technology and business research and development company dedicated to developing and marketing niche products and applications to meet the ...
Syntonix discovers and develops novel, long-acting, proprietary therapeutic products using the company's proprietary Fc-fusion proteins and other engineered ...
Nov 13, 2023 · Syntonix, a privately held biopharmaceutical company focused on discovering and developing long-acting therapeutic products to improve treatment ...
$9.95
Syntonix Pharmaceuticals, a Boston biopharmaceutical startup company, was seeking additional financing for growth. The company had developed and patented an ...
Syntonix currently occupies a 25,000 square foot state-of-the-art laboratory facility, including a cGMP clinical manufacturing suite, in Waltham, Massachusetts.
US drugmaker Biogen Idec has signed a definitive agreement to acquire fellow USA-based Syntonix, a privately-held company focused on discovering and ...
Syntonix is developing next generation biopharmaceuticals that enable better treatment options for patients with devastating chronic diseases such as ...
